<DOC>
	<DOC>NCT01353105</DOC>
	<brief_summary>Only about 15% of the potential candidates for lung donation are considered suitable for transplantation. A new method for ex vivo lung perfusion (EVLP) has been developed and can be used for evaluation and reconditioning of "marginal" and unacceptable lungs. The Â´purpose of this study is to analyse the executability and safety of ex vivo lung perfusion pulmonary ex vivo in marginal donors.</brief_summary>
	<brief_title>Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion</brief_title>
	<detailed_description>Donor Inclusion criteria: - Age &lt; 55 years-old; - Smoking history &lt; 20 pack-year; - Clear chest radiograph; - Absence of significant chest trauma; - Absence of purulent secretions and gastric contents at bronchoscopy; - PaO2 &lt; 300 mm Hg (FIO2 1.0, PEEP 5 cmH2O) Exclusion criteria: - Lungs presenting PO2 &lt; 400 mmHg after ex vivo lung perfusion</detailed_description>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<criteria>Age &lt; 55 yearsold; Smoking history &lt; 20 packyear; Clear chest radiograph; Absence of significant chest trauma; Absence of purulent secretions and gastric contents at bronchoscopy; PaO2 &lt; 300 mm Hg (FIO2 1.0, PEEP 5 cmH2O) Lungs presenting PO2 &lt; 400 mmHg after ex vivo lung perfusion</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>pulmonary fibrosis</keyword>
</DOC>